Compare DOX & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DOX | BIO |
|---|---|---|
| Founded | 1982 | 1952 |
| Country | United States | United States |
| Employees | N/A | 7450 |
| Industry | EDP Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 7.1B |
| IPO Year | 1998 | N/A |
| Metric | DOX | BIO |
|---|---|---|
| Price | $66.37 | $262.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | $92.33 | ★ $358.50 |
| AVG Volume (30 Days) | ★ 1.4M | 302.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 3.40% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.46 | $2.51 |
| Revenue Next Year | $3.72 | $3.17 |
| P/E Ratio | $13.65 | ★ $9.72 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $65.74 | $211.43 |
| 52 Week High | $94.61 | $343.12 |
| Indicator | DOX | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 33.69 | 36.10 |
| Support Level | N/A | $239.33 |
| Resistance Level | $70.61 | $264.68 |
| Average True Range (ATR) | 1.92 | 7.79 |
| MACD | 0.17 | -0.22 |
| Stochastic Oscillator | 13.39 | 12.17 |
Amdocs Ltd is a provider of software and services to communications, entertainment, and media service providers. The Company operates in a single segment and designs, develops, markets, supports, implements, and operates open and modular cloud offerings. Its portfolio includes solutions across digital business systems and legacy business and operational support systems, supporting multiple lines of business such as wireless, broadband, cable, fiber, satellite, and digital services. The Company leverages artificial intelligence to support digital transformation, cloud adoption, and intelligent network automation. Geographically, it derives a majority of its revenue from North America and also operates in Europe and the rest of the world.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.